BridgeMD
New treatment option for Bracket Bonding
Official title A Split-Mouth Clinical Trial Evaluating the Bond Failure Rate of a New Etch-Free Orthodontic Adhesive
ClinicalTrials.gov ID: NCT07091422
What this study is testing
- What it's testing
- This randomized, split-mouth clinical trial will evaluate a new orthodontic adhesive that eliminates the need for acid etching before bracket bonding. Conventional orthodontic bonding requires etching enamel with phosphoric acid, which can weaken the outer enamel layer and increase the risk of white spot lesions and enamel damage.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 35. Healthy volunteers may be eligible.
You may be able to join if
- Patients aged 14 to 35 years
- Requiring comprehensive fixed orthodontic treatment with brackets on both arches
- Good general health with no contraindications to orthodontic treatment
- Presence of at least 10 permanent teeth per arch suitable for bracket bonding
- Ability and willingness to comply with study visits and follow-up for at least 12 months
You likely can't join if
- Presence of systemic diseases or conditions that affect oral health or healing (e.g., uncontrolled diabetes, immunosuppression)
- Teeth with significant enamel defects, restorations, or caries in bonding areas
- Patients currently undergoing or who have undergone orthodontic treatment previously
- History of allergy or sensitivity to dental adhesives or related materials
- Patients with poor oral hygiene or active periodontal disease
- Use of medications known to affect tooth enamel or oral tissues (e.g., long-term corticosteroids)
See the full eligibility criteria
- Patients aged 14 to 35 years
- Requiring comprehensive fixed orthodontic treatment with brackets on both arches
- Good general health with no contraindications to orthodontic treatment
- Presence of at least 10 permanent teeth per arch suitable for bracket bonding
- Ability and willingness to comply with study visits and follow-up for at least 12 months
- Parent/guardian consent and child assent obtained as appropriate
- Presence of systemic diseases or conditions that affect oral health or healing (e.g., uncontrolled diabetes, immunosuppression)
- Teeth with significant enamel defects, restorations, or caries in bonding areas
- Patients currently undergoing or who have undergone orthodontic treatment previously
- History of allergy or sensitivity to dental adhesives or related materials
- Patients with poor oral hygiene or active periodontal disease
- Use of medications known to affect tooth enamel or oral tissues (e.g., long-term corticosteroids)
- Inability to attend follow-up visits or anticipated lack of compliance
- Participation in another clinical trial that could interfere with study outcomes
The study team makes the final eligibility decision.
Where it's taking place
- Baltimore, Maryland, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years to 35 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Baltimore, Maryland, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.